TMCnet News
For a Third Consecutive Year Therapure Biopharma Inc. Ranks in the PROFIT 500 List of the Fastest-Growing Companies in Canada and Ranks 10th in the GTA Manufacturing Sector (2nd Largest Employer)Therapure Biopharma Inc. is pleased to announce that it placed 121th in the annual PROFIT 500 ranking of Canada's Fastest-Growing Companies by Canadian Business and PROFIT (PROFITguide.com). The ranking is based on Canada's most successful growth companies using their five-year revenue growth. Therapure is especially pleased to announce that it ranked 24th on the list of Canada's Fastest-Growing Manufacturing Companies in 2015. "Companies become a part of the PROFIT 500 through innovative thinking, smart strategy and sheer grit," says James Cowan, Editor-in-chief of PROFIT and Canadian Business. "These firms demonstrate what Canadian entrepreneurs can achieve, both at home and across the globe." Closer to home in the GTA (News - Alert), Therapure ranked 10th overall and is the second largest employer within the manufacturing sector. As a contract development manufacturing organization (CDMO) of biologic therapeutics, Therapure is involved with technologically complex and extremely regulated processes attracting highly skilled employees who made this award possible. "Therapure is honoured to be in the PROFIT 500 ranking for a third consecutive year," says Nick Green, Therapure's President and CEO. "Our talented and dedicated people are passionate about making a difference and having a positive impact on people's lives." In addition to continued growth in revenue and job creation, Therapure recently celebrated one million hours without a lost-time accident. "This milestone is an excellent achievement which demonstrates our collective efforts and commitment to provide a safe working environment. This accomplishment is particularly impressive considering the growth and activities we've experienced over the last 8 years," says Green. "The health, safety and well-being of our employees and the public is a key foundation of our business." Therapure Biomanufacturing's capabilties and expertise include cell line development, upstream and downstream process development, cGMP manufacturing for preclinical, clinical and commercial drug supply and aseptic fill/finish of injectable drugs. These integrated services allow Therapure to compete successfully in the global biomanufacturing sector.
About Therapure Biopharma Inc. Visit www.therapurebio.com for more information about Therapure Biopharma Inc. and its divisions.
About PROFIT
Canadian
Business
PROFITguide.com Visit www.therapurebio.com for more information about Therapure Biopharma Inc. and its divisions.
View source version on businesswire.com: http://www.businesswire.com/news/home/20160930005891/en/ |